Inhibition of EGFR-AKT Axis Results in the Suppression of Ovarian Tumors In Vitro and in Preclinical Mouse Model

• Sivakumar Loganathan ,

  Contributed equally to this work with: Sivakumar Loganathan, Prabodh K. Kandala

  Affiliation Department of Pharmacology and University of Pittsburgh Cancer Institute, University of Pittsburgh, Pennsylvania, United States of America

  ⨯
• Prabodh K. Kandala ,

  Contributed equally to this work with: Sivakumar Loganathan, Prabodh K. Kandala

  Affiliation Department of Biomedical Sciences and Cancer Biology Center, Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America

  ⨯
• Parul Gupta,

  Affiliation Department of Biomedical Sciences and Cancer Biology Center, Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America

  ⨯
• Sanjay K. Srivastava

  * E-mail: sanjay.srivastava@ttuhsc.edu

  Affiliations Department of Pharmacology and University of Pittsburgh Cancer Institute, University of Pittsburgh, Pennsylvania, United States of America, Department of Biomedical Sciences and Cancer Biology Center, Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America

  ⨯